Drug intelligence / Profile preview

netilmicin + dexamethasone

Development stage
Phase 3
Lead developer
SIFI
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Ophthalmic, Topical
01

Overview

Netilmicin + dexamethasone is a fixed-dose ophthalmic combination of an aminoglycoside antibiotic (netilmicin) and a corticosteroid (dexamethasone). It is primarily used for the treatment of ocular inflammatory conditions where there is a risk or presence of superficial bacterial infection. Dexamethasone acts as a potent anti-inflammatory agent by inhibiting the release of arachidonic acid and subsequent production of pro-inflammatory mediators such as prostaglandins and leukotrienes. Netilmicin provides broad-spectrum antibacterial activity by inhibiting bacterial protein synthesis at the 30S ribosomal subunit, making it effective against various Gram-positive and Gram-negative bacteria, including methicillin-resistant strains. The combination has demonstrated efficacy in reducing signs and symptoms associated with conjunctival inflammation, postoperative ocular inflammation (such as after cataract surgery), and posterior blepharitis in moderate-severe dry eye patients[1][2][3][4][5][6].

Brand names
Netildex
Other names
dexamethasone/netilmicinnetilmycin/dexamethasonedexa/net
02

Targets

Bacterial RibosomeGR (Glucocorticoid receptor)

Beyond the preview

Go deeper on netilmicin + dexamethasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on netilmicin + dexamethasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call